ResolutionMD Passes FDA Hurdle for Mobile Devices

Calgary Scientific Inc’s enterprise image-viewing solution ResolutionMD has received FDA clearance for diagnostic use with mobile devices for all modalities. The software was found to be equivalent to a PACS or dedicated diagnostic workstation.

Canada Follows US Lead with Radiation Awareness Campaign

The Ontario Association of Radiologists (OAR) has announced its support for the Choosing Wisely Canada (CWC) campaign launched April 2 by the Canadian Medical Association. The campaign, based on a similar effort underway in the United States, aims to raise awareness about appropriate imaging and stimulate physician/patient dialogue about unnecessary procedures that could lead to excessive radiation exposure.

Intelerad Launches UK Tour to Promote PACS

Intelerad Medical Systems has announced a series of events in the UK this month to promote the opening of their Manchester office and to highlight the company’s IntelePACS system.

ASRT Looks to New Officers for 2014

The American Society of Technologic Radiologists has announced the election of three new officers to serve on its 2014-2015 board of directors in the positions of president-elect, vice president, and secretary-treasurer.

dreamstime_9002717

Is the ‘Gold Standard’ Tarnished?

An article published today (April 2, 2014) in The Journal of the American Medical Association (JAMA) explores the benefits and risks of mammography screening, and the authors’ conclusions are stirring up controversy.

National Campaign Passes the Baton for Cancer Funding

Siemens and the Entertainment Industry Foundation’s Stand Up to Cancer program are spearheading “The Baton Pass,” a campaign that aims to shorten the time it takes to translate new therapies from the research lab into clinical practice.

Charles Hoo

Nightshift Radiology Welcomes New Physician to Team

Nightshift Radiology, a national teleradiology service specializing in primary reads for community-based clients, has announced the addition of board-certified radiologist Charles Hoo, MD, to its team.